• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国咸宁地区妇女高危型人乳头瘤病毒的流行情况及基因型分布。

The prevalence and genotype distribution of high-risk human papillomaviruses among women in Xianning, China.

机构信息

Department of Gynecology, Xianning Central Hospital, The First Affiliated Hospital of Hubei University of Science and Technology, Xianning, Hubei, 437000, China.

出版信息

Virol J. 2024 Jun 18;21(1):140. doi: 10.1186/s12985-024-02413-y.

DOI:10.1186/s12985-024-02413-y
PMID:38890675
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11186159/
Abstract

BACKGROUND

The persistent infection of high-risk Human papillomavirus(HPV) is considered the main cause of cervical intraepithelial neoplasia and cervical cancer. But various cervical lesions caused by HPV infection can be properly prevented by timely vaccination. However, the distribution of HPV genotypes varies geographically.

METHODS

Retrospective analysis of high-risk HPV prevalence of 16,150 women from 2020 to 2022 in xianning of China. HPV genotyping was performed using a PCR-RDB Kit that can detect 18 high-risk HPV genotypes recommended by China's National Medical Products Administration. The prevalence of 18 high-risk HPV genotypes and their relationship with cervical lesions as well as vaccine efficacy were analyzed.

RESULTS

A total of 2431 women were confirmed to have different types of high-risk HPV infections. The overall positive rate reached 15.05%(2431/16,150). The most prevalent high-risk HPV genotypes were HPV52, 16, 58, 53, and 51. The prevalence of high-risk HPV reached peak at age ≤ 20(20.95%) and age ≥ 61(20.56%). The most prevalent high-risk HPV genotypes were HPV16, 58, 18, 33 and 52 in cervical cancer cases, HPV16, 52, 58, 33 and 18 in CIN2/3 cases, and HPV52, 58, 16, 53 and 18 in CIN1 cases, respectively.

CONCLUSION

HPV16, 58 and 18 are the most dangerous and carcinogenic genotypes in xianning, China. Conducting epidemiological investigations on high-risk HPV has significant clinical value in guiding HPV vaccination work.

摘要

背景

高危型人乳头瘤病毒(HPV)的持续感染被认为是导致宫颈上皮内瘤变和宫颈癌的主要原因。但 HPV 感染引起的各种宫颈病变可以通过及时接种疫苗得到适当预防。然而,HPV 基因型的分布在地理上存在差异。

方法

回顾性分析了 2020 年至 2022 年中国咸宁 16150 名女性的高危型 HPV 流行情况。采用 PCR-RDB 试剂盒进行 HPV 基因分型,该试剂盒可检测中国国家药品监督管理局推荐的 18 种高危型 HPV 基因型。分析了 18 种高危型 HPV 基因型的流行情况及其与宫颈病变的关系以及疫苗的有效性。

结果

共有 2431 名女性被确认为患有不同类型的高危型 HPV 感染。总阳性率达到 15.05%(2431/16150)。最常见的高危型 HPV 基因型是 HPV52、16、58、53 和 51。高危型 HPV 的流行率在年龄≤20 岁(20.95%)和年龄≥61 岁(20.56%)达到高峰。宫颈癌病例中最常见的高危型 HPV 基因型是 HPV16、58、18、33 和 52,CIN2/3 病例中最常见的高危型 HPV 基因型是 HPV16、52、58、33 和 18,CIN1 病例中最常见的高危型 HPV 基因型是 HPV52、58、16、53 和 18。

结论

HPV16、58 和 18 是中国咸宁最危险和致癌性最强的基因型。对高危型 HPV 进行流行病学调查对指导 HPV 疫苗接种工作具有重要的临床价值。

相似文献

1
The prevalence and genotype distribution of high-risk human papillomaviruses among women in Xianning, China.中国咸宁地区妇女高危型人乳头瘤病毒的流行情况及基因型分布。
Virol J. 2024 Jun 18;21(1):140. doi: 10.1186/s12985-024-02413-y.
2
Prevalence and genotype distribution of HPV combined with cervical pathological results in women from Sichuan, China: A cross-sectional study based on post-vaccination period 2019 to 2023.中国四川女性 HPV 感染与宫颈病变的流行率及基因型分布:基于疫苗接种后时期(2019-2023 年)的横断面研究。
Cancer Med. 2024 Aug;13(16):e70148. doi: 10.1002/cam4.70148.
3
Prevalence of Human Papillomavirus Genotypes Among Women With High-Grade Cervical Lesions in Beijing, China.中国北京高级别宫颈病变女性中人乳头瘤病毒基因型的流行情况
Medicine (Baltimore). 2016 Jan;95(3):e2555. doi: 10.1097/MD.0000000000002555.
4
Prevalence and genotype distribution of human papillomavirus in women with cervical cancer or cervical intraepithelial neoplasia in Henan province, central China.中国中部河南省宫颈癌或宫颈上皮内瘤变妇女中人类乳头瘤病毒的流行状况和基因型分布。
J Med Virol. 2020 Dec;92(12):3743-3749. doi: 10.1002/jmv.25670. Epub 2020 Mar 1.
5
Human papillomavirus infections among women with cervical lesions and cervical cancer in Eastern China: genotype-specific prevalence and attribution.中国东部宫颈病变及宫颈癌女性中的人乳头瘤病毒感染:基因型特异性流行率及归因分析
BMC Infect Dis. 2017 Jan 31;17(1):107. doi: 10.1186/s12879-017-2223-1.
6
Characterization of human papillomavirus genotypes infections in patients with cervical lesions and cervical cancer in Urumqi, Xinjiang from 2016 to 2023.2016年至2023年新疆乌鲁木齐市宫颈病变和宫颈癌患者人乳头瘤病毒基因型感染情况分析
Virol J. 2025 Mar 13;22(1):72. doi: 10.1186/s12985-025-02674-1.
7
Distribution of human papillomavirus infection: a population-based study of cervical samples from Jiangsu Province.人乳头瘤病毒感染的分布:江苏省宫颈样本的基于人群的研究。
Virol J. 2019 May 20;16(1):67. doi: 10.1186/s12985-019-1175-z.
8
High-risk human papillomavirus genotype distribution and attribution to cervical cancer and precancerous lesions in a rural Chinese population.中国农村人群高危型人乳头瘤病毒基因型分布及其与宫颈癌和癌前病变的关系
J Gynecol Oncol. 2017 Jul;28(4):e30. doi: 10.3802/jgo.2017.28.e30.
9
Roles of extended human papillomavirus genotyping and multiple infections in early detection of cervical precancer and cancer and HPV vaccination.人乳头瘤病毒(HPV)基因分型和多重感染在宫颈癌前病变和癌症的早期检测及 HPV 疫苗接种中的作用
BMC Cancer. 2022 Jan 6;22(1):42. doi: 10.1186/s12885-021-09126-3.
10
Prevalence and distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia in China: a meta-analysis.中国宫颈上皮内瘤变中人乳头瘤病毒基因型的流行率和分布:一项荟萃分析。
Arch Gynecol Obstet. 2020 Dec;302(6):1329-1337. doi: 10.1007/s00404-020-05787-w. Epub 2020 Sep 10.

引用本文的文献

1
Study on the detection rate, genetic polymorphism, viral load, persistent infection capacity, and pathogenicity of human papillomavirus type 33.人乳头瘤病毒33型的检出率、基因多态性、病毒载量、持续感染能力及致病性研究
Virol J. 2025 Apr 26;22(1):121. doi: 10.1186/s12985-025-02752-4.
2
Study on the clinical characteristics, persistent infection capability, and viral load of human papillomavirus type 82 single infection.82型人乳头瘤病毒单一感染的临床特征、持续感染能力及病毒载量研究
Virol J. 2025 Mar 10;22(1):68. doi: 10.1186/s12985-025-02688-9.
3
Study on the clinical characteristics, persistent infection capability and viral load of human papillomavirus type 26 single infection.人乳头瘤病毒 26 型单感染的临床特征、持续感染能力及病毒载量研究。
Virol J. 2024 Nov 23;21(1):301. doi: 10.1186/s12985-024-02582-w.

本文引用的文献

1
Immunogenicity, efficacy, and safety of human papillomavirus vaccine: Data from China.人乳头瘤病毒疫苗的免疫原性、疗效和安全性:来自中国的数据。
Front Immunol. 2023 Mar 13;14:1112750. doi: 10.3389/fimmu.2023.1112750. eCollection 2023.
2
Human papillomavirus (HPV) vaccines in adults: Learnings from long-term follow-up of quadrivalent HPV vaccine clinical trials.人乳头瘤病毒(HPV)疫苗在成年人中的应用:四价 HPV 疫苗临床试验长期随访结果。
Hum Vaccin Immunother. 2023 Dec 31;19(1):2184760. doi: 10.1080/21645515.2023.2184760. Epub 2023 Mar 13.
3
Cancer of the cervix uteri: 2021 update.子宫颈癌:2021 年更新。
Int J Gynaecol Obstet. 2021 Oct;155 Suppl 1(Suppl 1):28-44. doi: 10.1002/ijgo.13865.
4
Prevalence and genotype distribution of high-risk HPV infection among women in Beijing, China.中国北京地区女性高危型人乳头瘤病毒感染的流行状况及基因型分布。
J Med Virol. 2021 Aug;93(8):5103-5109. doi: 10.1002/jmv.27013. Epub 2021 May 3.
5
Prevalence characteristics of cervical human papillomavirus (HPV) infection in the Zhoupu District, Shanghai City, China.上海市周浦区宫颈人乳头瘤病毒(HPV)感染的流行特征。
Virol J. 2020 Jun 26;17(1):84. doi: 10.1186/s12985-020-01352-8.
6
Positivity and prevalence of human papillomavirus among a large population of women in southeastern China.中国东南部大量女性人群中人乳头瘤病毒的阳性率及流行情况。
J Int Med Res. 2019 Dec;47(12):6171-6181. doi: 10.1177/0300060519870918. Epub 2019 Sep 6.
7
Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis.2018 年宫颈癌发病率和死亡率的估计:全球分析。
Lancet Glob Health. 2020 Feb;8(2):e191-e203. doi: 10.1016/S2214-109X(19)30482-6. Epub 2019 Dec 4.
8
[Report of cancer epidemiology in China, 2015].《2015年中国癌症流行病学报告》
Zhonghua Zhong Liu Za Zhi. 2019 Jan 23;41(1):19-28. doi: 10.3760/cma.j.issn.0253-3766.2019.01.005.
9
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
10
Efficacy of quadrivalent human papillomavirus vaccine against persistent infection and genital disease in Chinese women: A randomized, placebo-controlled trial with 78-month follow-up.四价人乳头瘤病毒疫苗在中国女性人群中针对持续性感染和生殖器疾病的效力:一项随机、安慰剂对照、随访 78 个月的临床试验。
Vaccine. 2019 Jun 12;37(27):3617-3624. doi: 10.1016/j.vaccine.2018.08.009. Epub 2018 Aug 16.